Akebia Therapeutics, Inc. financial data

Symbol
AKBA on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 188% % 37%
Quick Ratio 14% % -48%
Debt-to-equity 991% %
Return On Equity -17% % -110%
Return On Assets -1.5% % 95%
Operating Margin 10% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 267,879,239 shares 13%
Common Stock, Shares, Outstanding 265,424,818 shares 18%
Entity Public Float $946,381,036 USD 349%
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 257,157,782 shares 22%
Weighted Average Number of Shares Outstanding, Diluted 257,157,782 shares 22%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $236,196,000 USD 47%
Cost of Revenue $39,462,000 USD -38%
Research and Development Expense $62,359,000 USD 66%
Operating Income (Loss) $23,499,000 USD 40%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,721,000 USD 95%
Income Tax Expense (Benefit) $615,000 USD
Net Income (Loss) Attributable to Parent $5,345,000 USD 92%
Earnings Per Share, Basic -0.02 USD/shares 94%
Earnings Per Share, Diluted -0.02 USD/shares 94%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $184,844,000 USD 256%
Accounts Receivable, after Allowance for Credit Loss, Current $47,031,000 USD 37%
Inventory, Net $15,610,000 USD -3.9%
Other Assets, Current $3,771,000 USD -48%
Assets, Current $252,955,000 USD 122%
Property, Plant and Equipment, Net $1,222,000 USD -44%
Operating Lease, Right-of-Use Asset $3,663,000 USD -55%
Intangible Assets, Net (Excluding Goodwill) $0 USD -100%
Goodwill $59,044,000 USD 0%
Other Assets, Noncurrent $59,681,000 USD 60%
Assets $376,565,000 USD 71%
Accounts Payable, Current $21,185,000 USD 40%
Employee-related Liabilities, Current $11,018,000 USD 20%
Accrued Liabilities, Current $121,716,000 USD 92%
Contract with Customer, Liability, Current $2,681,000 USD
Liabilities, Current $162,938,000 USD 101%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $0 USD -100%
Other Liabilities, Noncurrent $1,823,000 USD -62%
Liabilities $343,955,000 USD 27%
Accumulated Other Comprehensive Income (Loss), Net of Tax $6,000 USD 0%
Retained Earnings (Accumulated Deficit) $1,683,705,000 USD -0.32%
Stockholders' Equity Attributable to Parent $32,610,000 USD
Liabilities and Equity $376,565,000 USD 71%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $13,587,000 USD 30%
Net Cash Provided by (Used in) Financing Activities $74,942,000 USD 306%
Net Cash Provided by (Used in) Investing Activities $154,000 USD
Common Stock, Shares Authorized 350,000,000 shares 0%
Common Stock, Shares, Issued 265,424,818 shares 18%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $61,509,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $186,543,000 USD 248%
Deferred Tax Assets, Valuation Allowance $382,001,000 USD -1.5%
Deferred Tax Assets, Gross $383,551,000 USD -2%
Operating Lease, Liability $3,548,000 USD -60%
Depreciation $314,000 USD -14%
Payments to Acquire Property, Plant, and Equipment $18,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $5,345,000 USD 92%
Lessee, Operating Lease, Liability, to be Paid $5,073,000 USD -53%
Operating Lease, Liability, Current $3,548,000 USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,613,000 USD -38%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,613,000 USD -38%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $65,000 USD -87%
Deferred Tax Assets, Operating Loss Carryforwards $289,712,000 USD -0.69%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Operating Lease, Payments $5,800,000 USD 1.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $27,031,000 USD -25%
Deferred Tax Assets, Net of Valuation Allowance $1,550,000 USD -54%
Share-based Payment Arrangement, Expense $11,283,000 USD 45%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%